Q&A: Mike Stapleton, COO of Pharmacopeia s New Software Unit, on Product Integration | GenomeWeb

As Pharmacopeia of Princeton, NJ, plans to merge its four software units into a single entity, the company faces a number of challenges in making the integration process as seamless as possible.

The new software business will incorporate Molecular Simulations, Genetics Computer Group, Oxford Molecular, and Synopsys Scientific Systems. The unit’s main sites will be based in San Diego, Calif., and Cambridge, UK. A name for the new business has been chosen, but will not be announced until the American Chemical Society Meeting in San Diego April 1-5.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.